Effect of penicillamine and zinc on iron metabolism in Wilson's disease

References

• Frydman M. Genetic aspects of Wilson's disease. J Gastroenterol Hepatol 1990; 5: 483–90
   PubMed Web of Science ®Google Scholar
• Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993; 5: 327–37
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344–50
   PubMed Web of Science ®Google Scholar
• Kato J, Kobune M, Kohgo Y, Sugawara N, Hisai H, Nakamura T, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest 1996; 98: 923–9
   PubMed Web of Science ®Google Scholar
• Hayashi H, Wakusawa S, Yano M. Iron removal by phlebotomy for the prophylaxis of fulminant hepatitis in a Wilson disease model of Long-Evans Cinnamon rats. Hepatol Res 2006; 35: 276–80
   PubMed Web of Science ®Google Scholar
• Sargent PJ, Farnaud S, Evans RW. Structure/function overview of proteins involved in iron storage and transport. Curr Med Chem 2005; 12: 2683–93
   PubMed Web of Science ®Google Scholar
• Hellman NE, Schaefer M, Gehrke S, Stegen P, Hoffman WJ, Gitlin JD, et al. Hepatic iron overload in aceruloplasminemia. Gut 2000; 47: 858–60
   PubMed Web of Science ®Google Scholar
• Schilsky M. The irony of treating Wilson's disease. Am J Gastroenterol 2001; 96: 3055–7
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004; 11: 251–4
   PubMed Web of Science ®Google Scholar
• Park CH, Valore EV, Warning AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806–10
   PubMed Web of Science ®Google Scholar
• Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 2003; 102: 371–6
   PubMed Web of Science ®Google Scholar
• Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003; 34: 97–101
   PubMed Web of Science ®Google Scholar
• Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004; 53: 735–43
   PubMed Web of Science ®Google Scholar
• Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037–44
   PubMed Web of Science ®Google Scholar
• Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596–601
   PubMed Web of Science ®Google Scholar
• Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, et al. Iron accumulation in the liver of male patients with Wilson's Disease. Am J Gastroenterol 2001; 96: 3147–51
   PubMed Web of Science ®Google Scholar
• Walshe JM, Dixon AK. Dangers of non-compliance in Wilson's disease. Lancet 1986; 12: 845–7
   Google Scholar
• Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 2005; 145: 139–43
   PubMed Web of Science ®Google Scholar
• Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998; 132: 264–78
   PubMed Web of Science ®Google Scholar
• Sharp P. The molecular basis of copper and iron interactions. Proc Nutr Soc 2004; 63: 563–9
   PubMed Web of Science ®Google Scholar
• Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006; 26: 323–42
   PubMed Web of Science ®Google Scholar
• Aoki CA, Rossaro L, Ramsamooj R, Brandhagen D, Burritt MF, Bowlus CL. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol 2005; 39: 71–4
   PubMed Web of Science ®Google Scholar
• Faa G, Nurchi V, Demelia L, Ambu R, Parodo G, Congiu T, et al. Uneven hepatic copper distribution in Wilson's disease. J Hepatol 1995; 22: 303–8
   PubMed Web of Science ®Google Scholar
• Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, et al. Detection of serum hepcidin in renal failure and inflammation by using the ProteinChip System. Blood 2006; 108: 1381–7
   PubMed Web of Science ®Google Scholar
• Brookes MJ, Sharma NK, Tselepis C, Iqbal TH. Serum pro-hepcidin: measuring active hepcidin or a non-functional precursor?. Gut 2005; 54: 169–73
   PubMed Web of Science ®Google Scholar
• Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. Leap-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480: 147–50
   PubMed Web of Science ®Google Scholar
• Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson disease: a cohort study. Gut 2006; 56: 115–20
   PubMed Web of Science ®Google Scholar